State Street SPDR S&P 600 Small Cap Growth ETF is rated a Buy due to its components strong and achievable earnings growth rate. Read more on SLYG stock here.

The FDA has opened the door to the use of Bayesian statistical methods in clinical trials. The worry: Introducing ...

Q4 2025 Earnings Call February 24, 2026 4:30 PM ESTCompany ParticipantsChinmay Shukla - Senior Vice President of ...

Tailored implementation strategies (activities designed to tackle specific challenges facing healthcare professionals trying to action a new practice or recommendation) likely lead to slight ...

First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to ...

Compass Pathways plc , a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful achievement of the primary endpoint in the ongoing ...

Recently, a collaborative effort among research centers in the United States and Europe resulted in the development of ...

Introduction Previous reviews have investigated the relationship between empathy and burnout. However, these are now out of date, did not capture the effect of the pandemic, did not include healthcare ...

Objectives Rising patient numbers and limited resources are creating a challenging environment for healthcare providers recently. Anaesthesiologists are also increasingly faced with complex situations ...

Of course, all of this now highly probable growth is underpinned by clinical data that we have already generated across our four Phase 3s as well as data that we continue to generate, and a commercial ...

Gossamer Bio, Inc. (Nasdaq: GOSS) a biopharmaceutical company focused on the development and commercialization of seralutinib ...